IOC Mandates SRY Gene Screening for Olympic Female Category Eligibility
Starting at the 2028 Los Angeles Games, the International Olympic Committee will require a one-time genetic test to determine eligibility for women's events, effectively barring transgender women and many athletes with differences of sex development.
By Aylin Aksoy
- Olympic Governing Bodies
- Prioritize a universal, clear biological standard to ensure fairness and safety in the female category.
- Human Rights & Inclusion Advocates
- View mandatory genetic testing as an invasive violation of privacy that disproportionately harms intersex and transgender women.
- Geneticists & Medical Skeptics
- Argue that a single gene test cannot accurately capture the complexity of human sex development and hormone processing.
The short answer
- The IOC will mandate a one-time SRY gene screening for all athletes in the female category starting at the 2028 LA Olympics.
- Athletes testing positive for the SRY gene will be ineligible for women's events, with rare exceptions for conditions like Complete Androgen Insensitivity Syndrome.
- The policy effectively bans transgender women and many athletes with Differences of Sex Development (DSDs) from female Olympic competition.
- Proponents argue the rule ensures fairness and safety by establishing a clear biological boundary based on male sex development advantages.
- Critics, including the geneticist who discovered the SRY gene, argue the test is scientifically overly simplistic and violates athletes' human rights.
The most common misconception about biological sex is that it operates like a simple binary switch flipped by a single chromosome. In reality, human sex development is a cascading, multi-gene process that can produce a wide spectrum of physical traits. Yet, the International Olympic Committee (IOC) has decided to use one specific genetic marker as the ultimate gatekeeper for women's sports.[4]
Starting at the 2028 Los Angeles Games, the IOC will require all athletes competing in the female category to undergo a one-time genetic screening for the SRY (Sex-determining Region Y) gene. This replaces years of shifting, sport-by-sport standards regarding testosterone suppression with a single, universal test.[3]
The policy mandates that anyone testing positive for the SRY gene—which is typically found on the Y chromosome and is responsible for initiating male sex development in utero—will be permanently ineligible for female events. The IOC allows for very rare exceptions, such as athletes diagnosed with Complete Androgen Insensitivity Syndrome (CAIS), who possess the gene but do not physically process testosterone.[3]
For athletes and sports administrators, this means preparing for a rigid new reality. A simple saliva, cheek swab, or blood test will now dictate an athlete's Olympic future. The IOC, under President Kirsty Coventry, argues this establishes a clear, science-based standard that protects fairness and safety in the female category.[3]

However, it is vital to flag the scientific uncertainty surrounding this approach rather than overselling the gene as a flawless biological boundary. The scientific community is deeply divided on whether this single gene can bear the weight of such a massive policy. Andrew Sinclair, the geneticist who actually discovered the human SRY gene in 1990, has publicly criticized the IOC's approach as "overly simplistic."[4]
However, it is vital to flag the scientific uncertainty surrounding this approach rather than overselling the gene as a flawless biological boundary.
Sinclair and other researchers point out that while the SRY gene initiates testicular development, it does not guarantee how the body ultimately processes hormones or develops physical traits. Some individuals with XY chromosomes and the SRY gene develop female physical characteristics, while others without the gene develop male traits. The presence of the gene alone, experts warn, does not definitively prove a physical performance advantage.[1][4]
The practical impact of this policy is sweeping. It effectively bans all transgender women from the Olympic female category, regardless of how long they have undergone hormone therapy or gender-affirming care, because they retain the SRY gene.
It also ensnares athletes with Differences of Sex Development (DSDs), often referred to as intersex traits. High-profile athletes like South African runner Caster Semenya and Algerian boxer Imane Khelif have previously faced intense scrutiny over DSD regulations; under the new IOC rule, the presence of an SRY gene would automatically disqualify similar athletes from female categories, forcing them into male or open divisions.[1]

Proponents of the policy, including World Athletics President Sebastian Coe and advocacy groups like Sex Matters, celebrate the move. They argue that male puberty confers insurmountable physical advantages in bone density, lung capacity, and muscle mass that hormone suppression simply cannot undo, making a genetic boundary necessary.[2]
Conversely, human rights organizations and prominent athletes argue the policy is a discriminatory overreach. They point to the IOC's own history: mandatory chromosome testing was utilized for decades before being abandoned in 1999 after it produced false positives and caused immense psychological harm to female athletes who were unaware of their genetic variations.
The IOC maintains that the new screening is unintrusive and that athletes who screen positive will still be allowed to compete in male or open categories. Critics argue this is a false compromise for women who have lived, trained, and competed as females their entire lives.[3]
Ultimately, the policy forces a rigid biological line onto a complex genetic spectrum. It prioritizes a specific definition of competitive fairness over inclusivity, setting a precedent that will likely trickle down from the Olympic stage to national and grassroots sports federations worldwide.[1][2]
Why it matters
This policy replaces a confusing patchwork of sport-by-sport regulations with a single, universal genetic standard for the world's largest sporting stage. It fundamentally redefines who is legally and biologically permitted to compete in women's elite sports, impacting the careers of transgender and intersex athletes globally.
Competing readings
The Case For SRY Screening (Competitive Fairness)
Arguments supporting the policy focus on the physical advantages of male puberty and the need for a clear, universal standard.
Proponents of the SRY screening policy argue that fairness in the female category requires a strict biological boundary. Evidence cited by sports governing bodies suggests that male sex development—triggered by the SRY gene—confers lasting physical advantages, including greater bone density, larger lung capacity, and increased muscle mass. Advocates argue that because testosterone suppression therapies cannot fully reverse these structural advantages, a genetic test is the only objective way to ensure a level playing field. Furthermore, supporters highlight that a one-time, universal genetic swab is far less invasive and confusing than the previous system, which required athletes to constantly monitor and artificially suppress their natural hormone levels to meet arbitrary sport-by-sport thresholds.
The Case Against SRY Screening (Scientific Complexity & Inclusion)
Arguments opposing the policy highlight the scientific flaws of single-gene testing and the human rights implications for athletes.
Critics of the policy argue that it relies on a fundamental misunderstanding of human biology. Geneticists point out that the SRY gene is just one switch in a massive developmental control board; its presence does not guarantee that a body will process testosterone or develop male physical advantages. Opponents present evidence that roughly 1.7% to 2% of the population has natural variations in sex traits, meaning many athletes who have lived their entire lives as women could be abruptly disqualified by a single genetic marker. Furthermore, human rights advocates argue that mandatory genetic testing is an invasive violation of bodily autonomy, recalling the IOC's own history of chromosome testing in the 1990s, which was abandoned precisely because it produced false positives and caused severe psychological trauma to female athletes.
Practical Implementation Trade-offs
An analysis of where this policy succeeds administratively and where it fails biologically.
This policy fits well when a sports governing body requires a binary, easily administrable rule to separate categories across all disciplines. By relying on a one-time genetic test, the IOC eliminates the administrative burden of continuous hormone monitoring and provides a definitive 'yes or no' answer for eligibility. However, the policy does not fit when the goal is to accurately reflect the full biological spectrum of human sex development. It forces a complex genetic reality into a rigid binary, meaning that while the rule is easy to enforce, it will inevitably exclude athletes who possess the SRY gene but derive no actual physical performance advantage from it, prioritizing administrative clarity over biological nuance.
- 2028
- Year the policy takes effect (LA Games)
- 1
- Number of times an athlete must take the lifetime SRY screening
- 1.7–2.0%
- Estimated global population with variations in sex traits
What’s still unclear
- How national sports federations and grassroots organizations will adapt their own policies in response to the IOC's mandate.
- Whether the policy will face successful legal challenges in international courts or the Court of Arbitration for Sport before the 2028 Games.
- The exact protocols for handling false positives or protecting the privacy of athletes whose genetic results might be leaked to the public.
Sources
[1]TIMEGeneticists & Medical Skeptics
The IOC's New Genetic Testing Policy for Female Athletes, Explained
Read on TIME →[2]Inside the GamesOlympic Governing Bodies
Coe welcomes IOC SRY gene screening decision
Read on Inside the Games →[3]Olympics.comOlympic Governing Bodies
IOC Executive Board approves Policy on the Protection of the Female Category
Read on Olympics.com →[4]ScimexGeneticists & Medical Skeptics
Expert Reaction: IOC bans transgender women from female events, introduces SRY gene testing
Read on Scimex →
Comments
Every angle. Every day.
Get fitness stories with full source coverage and perspective breakdowns delivered to your inbox.








